Talk to a certified wellness coach free — a real 15-minute call, no cost, no card. Book your free call
OS Reboot
See if you qualify

Wegovy at a glance

An FDA-approved brand medication, available only when a licensed physician determines it is appropriate for you. Nothing is prescribed unless a licensed physician determines it is appropriate for you.

Protocol
Wegovy
Category
Branded GLP-1
Medicine type
Injection
Availability
Prescription only. An FDA-approved medication, supplied only where a licensed physician determines it is appropriate after an individual evaluation.
Dispensed by
A U.S. state-licensed pharmacy.

About Wegovy

What it is

A brand-name medicine from Novo Nordisk containing semaglutide, a GLP-1 receptor agonist. Unlike a compounded preparation, it is manufactured to a single approved formulation and reviewed by the FDA.

How it is used

Supplied through the affiliated medical network where a licensed physician determines it is right for you. Brand-name supply varies with manufacturer availability, so a physician may discuss alternatives.

What to discuss with your physician

Raise any personal or family history of medullary thyroid carcinoma or MEN 2, pancreatitis, gallbladder or kidney disease, and pregnancy or plans for it. Ask about the early gastrointestinal side effects most people notice first.

Educational information only. It is not medical advice and does not describe results you should expect. A licensed physician decides what, if anything, is appropriate for you.

Wegovy, explained

What Wegovy is

Wegovy is the brand name for semaglutide, a GLP-1 receptor agonist that is FDA-approved for chronic weight management in adults with obesity, or with overweight plus at least one weight-related condition, as an adjunct to a reduced-calorie diet and increased physical activity. It works by mimicking a hormone your body releases after eating — helping regulate appetite, slowing how quickly the stomach empties, and making it easier to eat less without feeling like you are fighting yourself. Through OS Reboot's affiliated medical network it is dispensed as a once-weekly self-administered injection or as an oral tablet — which form is appropriate for you, if either, is your physician's decision.

What its clinical trial showed

In STEP 1, the pivotal 68-week trial, adults taking the highest studied dose of semaglutide alongside a reduced-calorie diet and increased physical activity saw an average total body-weight reduction of 14.9%. That figure is the trial average for the approved medication — not a prediction of your result. Individual results vary, not everyone qualifies, and no outcome is guaranteed.

How you get it

You complete a private online evaluation, and a state-licensed physician in the affiliated medical network reviews your health history. Wegovy is prescription-only: it is prescribed only if that physician determines it is appropriate for you, and you are charged for medication only after a prescription is issued. If prescribed, it ships from a U.S. state-licensed pharmacy.

Common questions

Is Wegovy FDA-approved?
Yes. Wegovy (semaglutide) is FDA-approved for chronic weight management, as an adjunct to a reduced-calorie diet and increased physical activity. The 14.9% figure cited on this page comes from the STEP 1 trial, which studied the once-weekly injectable form.
Do I need a prescription?
Yes. Wegovy is prescription-only. A licensed physician reviews your evaluation and prescribes only if it is appropriate for you — not everyone qualifies.
Injection or tablet?
Both are dispensed: a once-weekly injection you give yourself, and an oral tablet. Which is right for you, if either, is your physician's call. Note that the STEP 1 trial figure cited on this page measured the injectable form.

Educational information only — not medical advice, a diagnosis, or a prescription, and no outcomes or weight-loss guarantees are made or implied. Every medical decision is made by a licensed physician based on your individual history. Medications carry risks and side effects — see the important safety information on this page. Not everyone qualifies.

osrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosreboot